IL1B and cardiovascular disorder: As drugs targeting IL-1β and IL-6 are available for use in cardiovascular disease treatment,42,83,84,85,86,87 further investigation of these interleukins in the disease manifestation and progression in adult human tissue and human disease models is critical.